COVID-19 in european urology Which lessons have we learned?
Por:
Rassweiler, JJ, Pini, G, Liatsikos, F, Georgiev, M, Roupret, M, Breda, A, Knoll, T, Micali, S, Stenzl, A, Goezen, AS, Yanev, K, Rassweiler-Seyfried, MC
Publicada:
1 mar 2021
Ahead of Print:
1 feb 2021
Resumen:
The coronavirus has challenged all medical systems worldwide. Herein both waves of COVID-19 (coronavirus disease 2019) in spring and autumn 2020 differ principally. Whereas Europe was hit by the first wave more or less unprepared, which was aggravated by the high virulence of COVID-19, the second wave is characterized by a much higher contagiosity of the virus with very high incidences. On the other hand the virus has attenuated, which is reflected by the significantly lower incidence-related mortality rate. However, the overall increasing number of infected patients represents again a great challenge for the medical management of the disease. France and Spain are doing better in comparison to Germany and Italy this time. The absolute number of deaths per week is higher than during the peak of the first wave. However, urologists in these countries have also experienced greater restrictions in their activities in the second shutdown than in Germany, where there is only a reduction of beds to between 75 and 90%. Mostly all levels are operated. Of importance for Germany, however, is the plateau on a high level for several weeks probably due to the reduced efficacy of a light lock-down. This finally resulted in a total lock-down in mid-December 2020. Subsequently in Germany some hospitals are also reaching their limits with similar consequences for the departments of urology facing a 50% reduction of beds and operating only level III and IV indications. Nevertheless, the management of urologic patients during the COVID-19 pandemic is carried out in Europa on a high standard. Therefor the risk of secondary harm to our patients is expected to be rather minimal in the long run.
Filiaciones:
Rassweiler, JJ:
Heidelberg Univ, Akad Lehrkrankenhaus, SLK Kliniken Heilbronn, Klin Urol & Kinderurol, Heidelberg, Germany
SLK Kliniken Heilbronn, Urol Klin, Gesundbrunnen 20, D-74074 Heilbronn, Germany
Pini, G:
IRCSS San Raffaele Hosp, Milan, Italy
Liatsikos, F:
Univ Patras, Dept Urol, Patras, Greece
Georgiev, M:
Med Univ Sofia, Dept Urol, Sofia, Bulgaria
Roupret, M:
Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, GRC 5 Predict ONCO URO,Urol, Paris, France
Breda, A:
Fundacio Puigvert, Dept Urooncol & Transplantat, Barcelona, Spain
Knoll, T:
Klinikum Sindelfingen Boblingen, Klinikverbund Sudwest, Urol Klin, Sindelfingen Boblingen, Germany
Micali, S:
Univ Modena & Reggio Emilia, Dept Urol, Modena, Italy
Stenzl, A:
Urol Univ Klin Tubingen, Tubingen, Germany
Goezen, AS:
Heidelberg Univ, Akad Lehrkrankenhaus, SLK Kliniken Heilbronn, Klin Urol & Kinderurol, Heidelberg, Germany
Yanev, K:
Med Univ Sofia, Dept Urol, Sofia, Bulgaria
Rassweiler-Seyfried, MC:
Univ Med Manheim, Klin Urol & Urochirurg, Mannheim, Germany
Bronze, Green Published
|